DBNL Antikörper (Middle Region)
Kurzübersicht für DBNL Antikörper (Middle Region) (ABIN631047)
Target
Alle DBNL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- DBNL antibody was raised against the middle region of DBNL
-
Aufreinigung
- Affinity purified
-
Immunogen
- DBNL antibody was raised using the middle region of DBNL corresponding to a region with amino acids QESAVHPREIFKQKERAMSTTSISSPQPGKLRSPFLQKQLTQPETHFGRE
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
DBNL Blocking Peptide, (ABIN5613128), is also available for use as a blocking control in assays to test for specificity of this DBNL antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DBNL antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DBNL (Drebrin-Like (DBNL))
-
Andere Bezeichnung
- DBNL
-
Hintergrund
- DBNL is an actin-binding adapter protein. DBNL may act as a common effector of antigen receptor-signaling pathways in leukocytes. Its association with dynamin suggests that it may also connect the actin cytoskeleton to endocytic function.
-
Molekulargewicht
- 48 kDa (MW of target protein)
-
Pathways
- T-Zell Rezeptor Signalweg, Regulation of Actin Filament Polymerization
Target
-